BBWI reports record Q4/FY21 earnings, CEO Meslow to step down in May due to health

Bath & Body Works, Inc.

Q4 net sales $3.027B (+11% YoY); GAAP EPS $2.27, adjusted EPS $2.30 (+17% YoY).
FY21 net sales $7.882B (+22%); adjusted EPS $4.51 (+45% YoY). Q1/FY22 guidance below prior year adjusted.
Board authorized $1.5B share repurchase program and 33% increase to annual dividend.
CEO Andrew Meslow steps down May 12, 2022 for health reasons; Board Chair Sarah Nash becomes Executive Chair and Interim CEO.
Board plans to retain a national search firm to identify permanent CEO.

item 2.02 item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed (interim)

Sarah E. Nash

Interim Chief Executive Officer

BBWI · Bath & Body Works, Inc.

Effective: 2022-05-12
Successor: Sarah E. Nash
Filed: February 23, 2022, 6:59 PM ET

Effective May 12, 2022, Ms. Nash will be appointed Interim Chief Executive Officer, and Andrew M. Meslow will step down as Chief Executive Officer and as a member of the Board due to health reasons.

Appointed

Sarah E. Nash

Executive Chair

BBWI · Bath & Body Works, Inc.

Effective: 2022-02-22
Filed: February 23, 2022, 6:59 PM ET

On February 22, 2022, the Board of Directors (the “Board”) of the Company appointed current Board Chair Sarah E. Nash as Executive Chair, effective immediately.

Departed

Andrew M. Meslow

Chief Executive Officer

BBWI · Bath & Body Works, Inc.

Effective: 2022-05-12
Successor: Sarah E. Nash
Filed: February 23, 2022, 6:59 PM ET

Effective May 12, 2022, Ms. Nash will be appointed Interim Chief Executive Officer, and Andrew M. Meslow will step down as Chief Executive Officer and as a member of the Board due to health reasons.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Sarah E. Nash was appointed as Interim Chief Executive Officer at Bath & Body Works, Inc..

Action: appointed
Role: Interim Chief Executive Officer

Exact text from the filing

Effective May 12, 2022, Ms. Nash will be appointed Interim Chief Executive Officer, and Andrew M. Meslow will step down as Chief Executive Officer and as a member of the Board due to health reasons.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Sarah E. Nash was appointed as Executive Chair at Bath & Body Works, Inc..

Action: appointed
Role: Executive Chair

Exact text from the filing

On February 22, 2022, the Board of Directors (the “Board”) of the Company appointed current Board Chair Sarah E. Nash as Executive Chair, effective immediately.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Andrew M. Meslow departed as Chief Executive Officer at Bath & Body Works, Inc..

Action: step down
Role: Chief Executive Officer

Exact text from the filing

Effective May 12, 2022, Ms. Nash will be appointed Interim Chief Executive Officer, and Andrew M. Meslow will step down as Chief Executive Officer and as a member of the Board due to health reasons.

View on SEC.gov

Bath & Body Works, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-22-026154

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.